Zydus begins human trials of its potential Covid-19 vaccine
July 17, 2020
The ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and funded by the Department of Biotechnology, has initiated phase I/II clinical trials in healthy subjects, making it the first indigenously developed vaccine for Covid-19 to be administered in humans in India. The adaptive Phase I/II dose escalation, multi-centric...
Read More